Sulzberger Gabrielle 4

What Happened
Gabrielle Sulzberger, a director of Eli Lilly & Co. (LLY), was granted/acquired 5.013 shares (transaction code A) on 2026-03-16. The shares were valued at $989.12 each for a total reported value of $4,958. This was an award of stock units (not an open‑market purchase or sale).

Key Details

• Transaction date and price: 2026-03-16; 5.013 shares at $989.12 per share (total $4,958).
• Transaction type: A = Award/Grant (stock units acquired).
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: The shares were elected to be deferred in lieu of cash compensation under the Lilly Directors' Deferral Plan and will be settled in shares following the reporting person's separation from service.
• Filing: Report filed 2026-03-17 for the 2026-03-16 transaction (appears timely under Form 4 rules).

Context
This is a routine director compensation award deferred into stock units; such deferred awards are common and do not reflect an open‑market purchase or sale by the director. The units will convert to common stock only upon the director’s separation from service, per the deferral plan.